This episode of The Nordic Venture Show podcast features MULTIVISIONdx, a company that transforms cancer diagnostics through AI-powered decision-support tools for personalized medicine. Their technology utilizes computer vision to integrate biological and spatial features of tumors, generating patient-specific profiles to assess aggressiveness and guide treatment. Spun out from the University of Helsinki, the company has achieved significant milestones, including a 650-patient proof-of-concept study published in Cell and various pitch competition wins.